The Health and Human Services department could wind up overpaying (or possibly underpaying) for the drugs for which it is negotiating a “maximum fair price” for Medicare under the Inflation Reduction Act, argue experts at the USC Schaeffer Center for Health Policy and Economics. A fuller picture of rebates and net prices could help that from happening, they say.
Do you favor Medicaid work requirements?
Researchers have identified an association between cataract surgery and a lower risk of cognitive decline and dementia.
For operational efficiency, value-based initiatives need a scalable digital infrastructure that can handle multiple reimbursement models, including fee for service.
The FDA approves Eohilia for eosinophilic esophagitis and Onivyde for metastatic pancreatic cancer but extends review of gene therapy for rare immune disorder. The agency also set goal dates for three products: full approval for Elevidys, Augtyro for solid tumors with NTRK gene fusions and seladelpar as for rare liver disease.
The results of this week’s poll about Super Bowl LVIII commercials.
This makes CSU treatment the sixth approved use globally.
The rule comes as health insurers have increasingly been criticized for onerous and time-consuming prior authorization procedures that physicians say unfairly delay or deny the medical treatment that their patients need.
The cheapest medication on the list is hydrochlorothiazide at $4.55.
SkinCure Oncology has not yet submitted its data to the FDA for marketing clearance, however once cleared, the new devices will use hybrid laser-generated confocal and photoacoustic imaging in a single fused volumetric image.
Published by Coherent Market Insights, the report shared the healthcare staffing market was valued at $36.89 billion in 2022.
This collaboration is the latest effort by a healthcare company to address social determinants of health.
Gary and Allison Stallings will celebrate their 20th anniversary this spring.
Which of these was your favorite Super Bowl commercial?
Study first of its kind to examine relationship.
The Inflation Reduction Act has helped to close some of the gaps in insurance coverage for vaccines, including some of the newly approved ones.
A study from Harvard Pilgrim Health Care Institute also found that patients with diabetes who were enrolled in a value-based medication benefit increased their use of antidiabetic medications.
Compared with gastric sleeve, more patients who underwent a gastric bypass surgery remained in remission from type 2 diabetes even if weight is regained.
These same employees are also not as comfortable sharing their struggles.
Up to 50% of women have reported that they struggle with sleep issues in midlife, while CVD stands as the main cause of death in women.
Each state’s best insurance company.
A large retrospective study of patients in South Korea shows that the SGLT2 inhibitors seem to do a better job with bringing about regression of nonalcoholic fatty liver disease.
The National Health Service provides some lessons — both good and bad — around models of coverage expansion.
2023 results are providing a "solid jump point into 2024," says Zubretsky. Like other insurers, Molina reported higher-than-expected Medicare spending.
The FDA has set PDUFA dates for several products: Arexvy to prevent RSV in 50 to the 59 population, for acoramidis in heart failure indication, and for an engineered tissue for vascular replacement. The agency has also scheduled an advisory committee meeting for Abecma in supplemental multiple myeloma indication. Additionally, Amneal has resubmitted its application for novel Parkinson’s therapy.
Providing support to those transitioning into life after incarceration is crucial. This group often faces complex health risks after their release, and maintaining consistent access to substance use disorder treatment plays a significant role in reducing the risk of reincarceration, relapse, and overdose.
In a retrospective study, researchers from Humana in Louisville, KY, compared clinical outcomes, time on treatment, healthcare resources utilization, and relative costs in patients with MS that were newly initiated on one of the following oral DMTs: dimethyl fumarate, fingolimod, or teriflunomide.
